We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.83%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$40.5B
AUM Growth
+$7.82B
(+24%)
Cap. Flow
+$9.9B
Cap. Flow
% of AUM
24.45%
Top 10 Holdings %
Top 10 Hldgs %
11.2%
Holding
4,410
New
905
Increased
1,516
Reduced
1,218
Closed
685
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$184M |
| 2 |
Dollar General
DG
|
+$152M |
| 3 |
MongoDB
MDB
|
+$129M |
| 4 |
Starbucks
SBUX
|
+$126M |
| 5 |
Costco
COST
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$111M |
| 2 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$97.7M |
| 3 |
Automatic Data Processing
ADP
|
+$90.7M |
| 4 |
Phillips 66
PSX
|
+$82.6M |
| 5 |
CVS Health
CVS
|
+$82.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 5.7% |
| 4 | Healthcare | 5.63% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Establishment Labs
ESTA
$2.72B
| $431K | ﹤0.01% |
+8,782
| New | +$525K |
|
2902
Genmab
GMAB
$17.7B
| $431K | ﹤0.01% |
12,213
-7,766
| -39% | -$296K |
|
2903
PUT
DigitalOcean
DOCN
$14.4B
| $430K | ﹤0.01% |
+17,900
| New | +$634K |
|
2904
HBT Financial
HBT
$1.21B
| $430K | ﹤0.01% |
23,570
+4,843
| +26% | +$92.2K |
|
2905
Northwest Bancshares
NWBI
$2.25B
| $429K | ﹤0.01% |
41,959
+10,644
| +34% | +$119K |
|
2906
iShares MSCI Australia ETF
EWA
$1.34B
| $429K | ﹤0.01% |
+19,935
| New | +$444K |
|
|
SILK
2907
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $428K | ﹤0.01% |
28,551
-71,365
| -71% | -$1.49M |
|
2908
Magna International
MGA
$17.9B
| $428K | ﹤0.01% |
7,976
-9,978
| -56% | -$581K |
|
2909
Cooper Companies
COO
$13.7B
| $427K | ﹤0.01% |
5,376
-2,204
| -29% | -$203K |
|
2910
ARKO Corp
ARKO
$890M
| $427K | ﹤0.01% |
+59,686
| New | +$467K |
|
2911
CALL
NovoCure
NVCR
$2.04B
| $426K | ﹤0.01% |
+26,400
| New | +$761K |
|
|
2912
PUT
NovoCure
NVCR
$2.04B
| $426K | ﹤0.01% |
+26,400
| New | +$761K |
|
2913
STAG Industrial
STAG
$7.86B
| $426K | ﹤0.01% |
12,339
-21,212
| -63% | -$770K |
|
2914
Primerica
PRI
$9.81B
| $424K | ﹤0.01% |
+2,188
| New | +$448K |
|
2915
CareTrust REIT
CTRE
$10.2B
| $424K | ﹤0.01% |
+20,689
| New | +$419K |
|
2916
Agios Pharmaceuticals
AGIO
$2.16B
| $423K | ﹤0.01% |
+17,107
| New | +$453K |
|
2917
Syndax Pharmaceuticals
SNDX
$1.84B
| $423K | ﹤0.01% |
29,120
-10,163
| -26% | -$192K |
|
2918
ESAB
ESAB
$5.25B
| $423K | ﹤0.01% |
6,019
+2,756
| +84% | +$192K |
|
2919
Kymera Therapeutics
KYMR
$9.1B
| $422K | ﹤0.01% |
+30,388
| New | +$611K |
|
|
ACCD
2920
DELISTED
Accolade Inc
ACCD
| $422K | ﹤0.01% |
39,899
-80,223
| -67% | -$1.05M |
|
2921
ACI Worldwide
ACIW
$5.72B
| $422K | ﹤0.01% |
18,706
-48,103
| -72% | -$1.12M |
|
2922
Lantheus
LNTH
$6.82B
| $422K | ﹤0.01% |
6,072
-84,551
| -93% | -$6.18M |
|
2923
CALL
TransDigm Group
TDG
$69.2B
| $422K | ﹤0.01% |
+500
| New | +$439K |
|
|
2924
PUT
TransDigm Group
TDG
$69.2B
| $422K | ﹤0.01% |
+500
| New | +$439K |
|
|
TWO
2925
Two Harbors Investment
TWO
$1.27B
| $421K | ﹤0.01% |
31,797
-14,157
| -31% | -$190K |
|
Similar funds
Squarepoint's Q3 2023 Portfolio in Review
As of Q3 2023, Squarepoint held 4,410 positions worth $40.5B, up 24% from $32.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $9.9B of net new capital in Q3 2023, opening 905 new positions and adding to 1,516 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Adobe, an estimated $111M trimmed.
- Squarepoint's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
- Squarepoint added most to Tesla in Q3 2023, an estimated $184M increase.
- Squarepoint's biggest Q3 2023 reduction was Adobe, cutting an estimated $111M.
- Squarepoint fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2023, selling an estimated $56.4M.
- Squarepoint's ten largest holdings make up 11% of its $40.5B portfolio in Q3 2023.
- Squarepoint opened 905 new positions and closed 685 in Q3 2023.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $40.5B.
Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.